Related Experiment Videos
Characteristics of blast crisis in chronic granulocytic leukemia
Insights
Blast crisis in chronic granulocytic leukemia presents as acute leukemia. This study identifies lymphoblastic and myeloblastic subgroups and highlights extramedullary leukemia as a key indicator of impending blast crisis.
Area of Science:
- Hematology
- Oncology
Background:
- The terminal phase of Philadelphia chromosome-positive chronic granulocytic leukemia (CGL), known as blast crisis (BC), clinically and hematologically mimics acute leukemia.
- Understanding the distinct features of BC is crucial for timely diagnosis and management.
Purpose of the Study:
- To review the clinical and hematologic characteristics of blast crisis in CGL.
- To identify morphological subgroups within blast crisis.
- To investigate the role of extramedullary leukemia in the onset of blast crisis.
Main Methods:
- Retrospective review of clinical and hematologic data from 73 patients with CGL.
- Morphological classification of blast crisis into lymphoblastic and myeloblastic subgroups.
- Documentation and analysis of extramedullary leukemia occurrences.
Main Results:
- Two predominant morphological subgroups were identified: lymphoblastic and myeloblastic.
- The lymphoblastic group exhibited more severe thrombocytopenia and higher blast counts.
- The myeloblastic group was characterized by more profound anemia.
- Extramedullary leukemia was observed in 27 patients, preceding or coinciding with BC in 12 patients.
Conclusions:
- Hematologic criteria for diagnosing blast crisis in CGL are proposed.
- Extramedullary leukemia is an important herald of blast crisis onset.
- Distinguishing between lymphoblastic and myeloblastic BC may inform treatment strategies.
Abstract:
The terminal phase of most patients with Ph1-positive chronic granulocytic leukemia (i.e., blast crisis) resembles acute leukemia. The clinical and hematologic features of blast crisis in 73 patients with chronic granulocytic leukemia have been reviewed. Two major morphological subgroups, lymphoblastic and myeloblastic, were identified. The lymphoblastic group in general had more profound thrombocytopenia and a greater number of blasts, while the myeloblastic group had more severa anemia. Extramedullary leukemia was documented in 27 patients. In 12 patients extramedullary leukemia preceded or occurred simultaneously with blast crisis in the bone marrow and peripheral blood. On the basis of this study we present hematologic criteria for the diagnosis of blast crisis and emphasize the importance of extramedullary leukemia in heralding the onset of blast crisis.